Atropine is an antimuscarinic (anticholinergic) medication that blocks acetylcholine at muscarinic receptors. In cardiology, it is primarily used as an acute therapy for certain types of symptomatic bradycardia. It acts on the cardiac conduction system—especially the sinoatrial (SA) node and atrioventricular (AV) node—to increase heart rate and AV nodal conduction. It is most commonly used in emergency and peri-procedural settings (e.g., Advanced Cardiovascular Life Support scenarios and monitored clinical environments).

Lidocaine is a medication that blocks sodium channels in nerves and cardiac cells. It is used as a local anesthetic and as an antiarrhythmic drug in selected settings. In cardiology, it is most associated with treatment of certain ventricular arrhythmias and with procedural anesthesia. It is commonly encountered in emergency care, electrophysiology contexts, and bedside procedures.

Amiodarone is an antiarrhythmic medication used to treat abnormal heart rhythms. It is part of pharmacologic therapy in cardiology rather than an anatomy or diagnostic test. It is commonly used for atrial and ventricular tachyarrhythmias in acute care and long-term rhythm control. It is notable for broad electrophysiologic effects and a long duration of action.

Digoxin is a cardiac glycoside medication used in cardiology. It affects heart muscle contraction and the cardiac conduction system. It is most commonly used in atrial fibrillation (AF) rate control and selected heart failure cases. It requires careful dosing and monitoring because its therapeutic window is narrow.

Aspirin is an oral medication in the salicylate class with analgesic, antipyretic, anti-inflammatory, and antiplatelet effects. In cardiology, it is primarily used as an antiplatelet therapy to reduce thrombus (clot) formation in arterial disease. It is commonly encountered in acute coronary syndrome (ACS), after percutaneous coronary intervention (PCI) with stenting, and in chronic coronary artery disease (CAD). It is also discussed in risk–benefit decisions around primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD).

Clopidogrel is an antiplatelet medication that reduces platelet-driven blood clot formation. It is used in cardiovascular and cerebrovascular medicine as part of medical therapy to prevent arterial thrombosis. It is commonly prescribed after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) with coronary stenting. It is also used in selected patients with ischemic stroke, transient ischemic attack (TIA), or peripheral artery disease (PAD).

Rivaroxaban is an oral anticoagulant medication used to reduce blood clot formation. It belongs to the class of direct oral anticoagulants (DOACs), specifically a direct factor Xa inhibitor. It is used in cardiovascular and thromboembolic conditions where preventing stroke, venous thromboembolism (VTE), or recurrent clotting is clinically important. It is commonly encountered in atrial fibrillation (AF), deep vein thrombosis (DVT), and pulmonary embolism (PE) care pathways.

Apixaban is an oral anticoagulant medication used to reduce blood clot formation. It is a therapy in cardiovascular and thromboembolic disease management. It is commonly used in atrial fibrillation and venous thromboembolism prevention or treatment. It is part of the direct oral anticoagulants (DOACs) class.

Warfarin is an oral anticoagulant medicine that reduces the blood’s tendency to form harmful clots. It is used in cardiovascular and thromboembolic diseases where clot prevention lowers the risk of stroke, systemic embolism, or venous thromboembolism (VTE). Warfarin is monitored using the international normalized ratio (INR), a standardized measure of blood clotting time. It is commonly prescribed in atrial fibrillation, mechanical heart valves, and selected high-risk clotting conditions.

Heparin is an anticoagulant medication used to reduce the formation and growth of blood clots. It is a therapy that acts on the coagulation system rather than on the heart muscle itself. It is commonly used in acute cardiovascular care, catheter-based procedures, and perioperative cardiothoracic settings. It is given by injection or intravenous infusion and is monitored with blood tests in many clinical uses.